AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AMIKACIN SULPHATE

11 registrations across 3 African markets— 8 active

Markets with AMIKACIN SULPHATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
LILIKACIN🇬🇭GhanaactiveJul 2030
LILIKACIN🇬🇭GhanaactiveJul 2030
SAFELINE - AMIKACIN SULPHATE 500🇿🇦South AfricaSafeline Pharmaceuticals (Pty) LtdsuspendedAug 2025
SAFELINE-AMIKACIN SULPHATE 250🇿🇦South AfricaSafeline Pharmaceuticals (Pty) LtdsuspendedAug 2025
SAFELINE-AMIKACIN SULPHATE 1 G🇿🇦South AfricaSafeline Pharmaceuticals (Pty) LtdsuspendedAug 2025
AMIKACIN SULPHATE
PARENTERAL ORDINARY VIALS
🇺🇬UgandaARISTO PHARMACEUTICA LS PVT LTDactive
AMIKACIN SULPHATE
PARENTERAL ORDINARY VIALS
🇺🇬UgandaARISTO PHARMACEUTICA LS PVT LTDactive
AMIKACIN SULPHATE
PARENTERAL ORDINARY VIALS
🇺🇬UgandaEGYPTIAN INTERNATIONAL PHARMACEUTICA L INDUSTRIES COMPANYactive
AMIKACIN SULPHATE
PARENTERAL ORDINARY VIALS
🇺🇬UgandaEGYPTIAN INTERNATIONAL PHARMACEUTICA L INDUSTRIES COMPANYactive
AMIKACIN SULPHATE
PARENTERAL ORDINARY AMPOULES
🇺🇬UgandaPHARMATHEN LTDactive
AMIKACIN SULPHATE
PARENTERAL ORDINARY AMPOULES
🇺🇬UgandaPHARMATHEN LTDactive

AMIKACIN SULPHATE in Africa — Regulatory Overview

AMIKACIN SULPHATE is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, South Africa, Ghana. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 8 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.